Poseida Lands $23,033,232 New Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5129a137-ed72-46d9-a194-c94f60d33d99 - Date
12/28/2015 - Company Name
Poseida - Mailing Address
4250 Executive Square La Jolla, CA 92037 USA - Company Description
Poseida Therapeutics is a spin out of Transposagen Biopharmaceuticals that utilizes best-in-class, proprietary genome editing technologies to develop targeted, life-saving therapeutics in areas of high unmet medical need. - Website
http://www.poseida.com - Transaction Type
Venture Equity - Transaction Amount
$23,033,232 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. - M&A Terms
- Venture Investor
Undisclosed
